BrachyBytes | January 2018 Newsletter Archive

2-Day Brachytherapy Trial Q&A

Welcome to 2018! This is an exciting, transformative time in breast cancer treatment, with advances neoadjuvant chemotherapy, wire-free tumor localization, and more tools for post-surgical radiation. Last year the TRIUMPH-T Trial for 2-day brachytherapy, completed patient enrollment and will begin to report out interim results as early as March 2018.  Trial investigator Atif J. Khan, MD provides a snapshot of this exciting trial.

Dr. Atif J. Khan

(866) 920-9444 | 6 Journey, Suite 125, Aliso Viejo, CA 92656

Thank you for being a BrachyBytes subscriber! We hope you found this issue to be informative. If you have any comments on how we could improve the BrachyBytes Report, we welcome all feedback and encourage you to email us at

This e-newsletter is brought to you by Cianna Medical, Inc., a women’s health company dedicated to the innovative treatment of early-stage breast cancer. As the only company dedicated exclusively to breast conservation therapy, Cianna’s commitment is to improve care and reduce the burden breast cancer treatment places on nearly 300,000 women and their loved ones each year.

© 2018 Cianna Medical